Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich M Lauer

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Cancers|December 30, 2025
Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and OutcomesRaphaela D Lewetag, Nils F Trautwein, Monika Zdanyte, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular CarcinomaMascha Mayer, Alexander Berger, Christian Leischner, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 21, 2018
6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma CellsSascha Venturelli, Heike Niessner, Tobias Sinnberg, et al.
Cancers|June 10, 2022
Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT CarcinomaPaul V Ohnesorge, Susanne Berchtold, Julia Beil, et al.
Journal of Virology|January 11, 2013
Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysisSusanne Berchtold, Johanna Lampe, Timo Weiland, et al.
Plos One|September 12, 2013
Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cellsSascha Venturelli, Alexander Berger, Alexander Böcker, et al.
Antioxidants (Basel, Switzerland)|September 28, 2024
Analysis of High-Dose Ascorbate-Induced Cytotoxicity in Human Glioblastoma Cells and the Role of Dehydroascorbic Acid and IronAlban Piotrowsky, Markus Burkard, Katharina Hammerschmidt, et al.
Plos One|December 29, 2012
Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphateTimo Weiland, Kathrin Klein, Martina Zimmermann, et al.
Viruses|February 28, 2023
Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis ModelJana Koch, Julia Beil, Susanne Berchtold, et al.
Clinical Nuclear Medicine|January 25, 2024
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot StudyNils Florian Trautwein, Clemens Hinterleitner, Lena Sophie Kiefer, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Cancers|December 30, 2025
Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and OutcomesRaphaela D Lewetag, Nils F Trautwein, Monika Zdanyte, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular CarcinomaMascha Mayer, Alexander Berger, Christian Leischner, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 21, 2018
6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma CellsSascha Venturelli, Heike Niessner, Tobias Sinnberg, et al.
Cancers|June 10, 2022
Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT CarcinomaPaul V Ohnesorge, Susanne Berchtold, Julia Beil, et al.
Journal of Virology|January 11, 2013
Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysisSusanne Berchtold, Johanna Lampe, Timo Weiland, et al.
Plos One|September 12, 2013
Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cellsSascha Venturelli, Alexander Berger, Alexander Böcker, et al.
Antioxidants (Basel, Switzerland)|September 28, 2024
Analysis of High-Dose Ascorbate-Induced Cytotoxicity in Human Glioblastoma Cells and the Role of Dehydroascorbic Acid and IronAlban Piotrowsky, Markus Burkard, Katharina Hammerschmidt, et al.
Plos One|December 29, 2012
Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphateTimo Weiland, Kathrin Klein, Martina Zimmermann, et al.
Viruses|February 28, 2023
Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis ModelJana Koch, Julia Beil, Susanne Berchtold, et al.
Clinical Nuclear Medicine|January 25, 2024
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot StudyNils Florian Trautwein, Clemens Hinterleitner, Lena Sophie Kiefer, et al.
Pageof 15